Muneer A Satter Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 12 months ago
Muneer A Satter has an estimated net worth of at least $10.8 million*, as of Nov. 27, 2024. They own 9.7 million shares of ANNX stock. They have sold 0 shares of ANNX stock since 2021, for an estimated $-28.4 million.
Muneer A Satter $ANNX SEC Form 4 Insider Trading
Muneer A Satter has filed a total of 8 insider trades in $ANNX since 2021. Their most recent trade was a purchase of 400,000 shares, made on Nov 20, 2025. Their largest trade was a purchase of 2.6 million shares, made on Feb 10, 2023. We estimate that they now own 9.7 million shares of $ANNX, worth an estimated $39.2 million.
Insider Trading at $ANNX
There have been a total of 63 insider trades reported at $ANNX since 2021, with 8.2 million shares purchased and 179,661 shares sold. The most active insider traders in $ANNX stock have been Ted Yednock, Jennifer Lew, and Michael Overdorf. The most recent trade was a purchase of 422,613 shares reported by Muneer A Satter (None), made on Nov 21, 2025.
History of Insider Stock Trades by Muneer A Satter
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ANNX
|
Purchase | 400,000 | Nov 20, 2025 | Nov. 21, 2025, 10:52 p.m. |
|
ANNX
|
Purchase | 422,613 | Nov 21, 2025 | Nov. 21, 2025, 10:52 p.m. |
|
ANNX
|
Purchase | 500,000 | Nov 19, 2025 | Nov. 19, 2025, 10 p.m. |
|
ANNX
|
Purchase | 500,000 | Nov 17, 2025 | Nov. 19, 2025, 10 p.m. |
|
ANNX
|
Purchase | 500,000 | Nov 18, 2025 | Nov. 19, 2025, 10 p.m. |
|
ANNX
|
Purchase | 350,000 | Dec 26, 2023 | Dec. 28, 2023, 5:30 p.m. |
|
ANNX
|
Purchase | 2.6 million | Feb 10, 2023 | Feb. 14, 2023, 5:31 p.m. |
|
ANNX
|
Purchase | 2.5 million | Jul 07, 2022 | July 11, 2022, 8:42 p.m. |
$ANNX Executives and Stock Owners with Insider Trades
-
Ted Yednock, EVP & CHIEF INNOVATION OFFICER
-
Jennifer Lew, EVP & CHIEF FINANCIAL OFFICER
-
Michael Overdorf, EVP & CHIEF BUSINESS OFFICER
-
Douglas Love, President & CEO
-
Jennifer Lew, EVP & Chief Financial Officer
-
Michael Overdorf, EVP & Chief Business Officer
-
Ted Yednock, EVP & Chief Scientific Officer
-
Douglas Love, PRESIDENT AND CEO
-
Dean Richard Artis, EVP & CHIEF SCIENTIFIC OFFICER
-
Jamie Dananberg, CHIEF MEDICAL OFFICER
-
Ted Yednock, EVP & Chief Innovation Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.